Yuanyuan Lv

4.0k citations
84 papers · 2.2k indexed · 1 hit paper · h-index 24
Topics
Cardiovascular and exercise physiology (8 papers)Heart Rate Variability and Autonomic Control (7 papers)Cardiovascular Health and Disease Prevention (6 papers)

In The Last Decade

Yuanyuan Lv

74 papers receiving 2.1k citations

Hit Papers

circNDUFB2 inhibits non-small cell lung cancer progressio...20212026202220242021100200300400

Peers

Yuanyuan Lv
Comparison fields: 5 of 128
  • Molecular Biology 1.2k
  • Cancer Research 870
  • Pulmonary and Respiratory Medicine 271
  • Oncology 211
  • Immunology 170
Replace Tao Tao with:
Tao Tao China
Jie Bai China
Xiaochuan Sun China
Chunjun Li China
Bing Zhou China
Xia Liu China
Keshen Li China
In Kyu Lee South Korea
Qingbo Guan China
Yuanyuan Lv relative to Tao Tao China Tao Tao's profile →
Citations per field
00.5×1.5×1.8×
Tao Tao · 1×
Citations per year

Countries citing papers authored by Yuanyuan Lv

Since Specialization
Citations

This map shows the geographic impact of Yuanyuan Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanyuan Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanyuan Lv more than expected).

Fields of papers citing papers by Yuanyuan Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanyuan Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanyuan Lv. The network helps show where Yuanyuan Lv may publish in the future.

Co-authorship network of co-authors of Yuanyuan Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanyuan Lv. A scholar is included among the top collaborators of Yuanyuan Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanyuan Lv. Yuanyuan Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 0
5 1
6 0
7 6
8 5
9 2
10 15
11 9
12 11
13 2
14 21
15 19
16 27
17 23
18 29
19 12
20 47

About Yuanyuan Lv

Yuanyuan Lv is a scholar working on Complementary and alternative medicine, Rehabilitation and Orthopedics and Sports Medicine, having authored 84 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cardiovascular and exercise physiology (8 papers), Heart Rate Variability and Autonomic Control (7 papers) and Cardiovascular Health and Disease Prevention (6 papers). The work is most often cited by research in Cancer Research (870 citations), Molecular Biology (1.2k citations) and Complementary and alternative medicine (107 citations). Yuanyuan Lv has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Chen Yang, Laikang Yu, Wenxin Qin, Cun Wang, Haojie Jin, Zhuoan Cheng, Siying Wang, Qiaozhu Zuo, Chengtao Yu and Botai Li. Their work appears in journals such as Nature Communications, PLoS ONE and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026